Subscribe To
Why bionano genomics, pacific biosciences of california, and sangamo therapeutics stocks crumbled this week
These cutting-edge biotech companies quickly fell out of favor with investors this week....
February 10, 2023, 11:01 am
Betting on biotech
Active investors can navigate the boom or bust biotech sector with the help of strategies like C-suite ...
February 10, 2023, 10:02 am
Why shares of aura biosciences jumped this week
The clinical-stage biotech may be ready to release updated phase 3 trial results on its lead therapy....
February 10, 2023, 6:03 am
Molecular partners to present at svb leerink global healthcare conference
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Feb. 10, 2023 (GLOBE NEWSWIRE) — Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage...
February 10, 2023, 6:00 am
Molecular partners to present at svb leerink global healthcare conference
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Feb. 10, 2023 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage ...
February 10, 2023, 1:00 am
Prometheus biosciences to present at the svb securities global biopharma conference
SAN DIEGO, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Prometheus Biosciences, Inc. (Nasdaq: RXDX), a clinical-stage biotechnology company pioneering a precisio...
February 9, 2023, 4:00 pm
Pharmaceutical companies losing patent protection as competition grows
The Wall Street Journal's Jared Hopkins joins 'Power Lunch' to discuss biotech patent protection durati...
February 9, 2023, 3:34 pm
Why compugen stock got slammed today
Clinical-stage biotechs are particularly susceptible to shifts in analyst sentiment....
February 8, 2023, 5:25 pm
2 top biotech stocks defying the bear market
These stocks soared in the double digits last year....
February 8, 2023, 2:00 pm
Design therapeutics to participate in the svb securities virtual global biopharma conference
CARLSBAD, Calif., Feb. 08, 2023 (GLOBE NEWSWIRE) — Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treat...
February 8, 2023, 11:30 am
Sana biotechnology: time and cash burn are the enemies
It's a challenging time for biotechs needing cash. Sana Biotechnology is such a company from the stable of Boston-based Flagship Pioneering....
February 8, 2023, 11:21 am
Why is lixte biotech (lixt) stock down 29% today?
Lixte biotech (NASDAQ: LIXT ) stock is dropping on Wednesday but it's not due to any negative news from...
February 8, 2023, 8:54 am
1 beaten-down stock that has a lot to prove in 2023
This biotech looks like a high-risk, high-reward play....
February 8, 2023, 8:05 am
Cellectis announces closing of global offering and exercise of underwriters’ option to purchase additional shares
NEW YORK, Feb. 07, 2023 (GLOBE NEWSWIRE) — Cellectis S.A. (“Cellectis” or the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinic...
February 8, 2023, 12:01 am
Tenaya therapeutics to participate in upcoming investor conferences
SOUTH SAN FRANCISCO, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) — Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with ...
February 7, 2023, 10:17 pm
Larimar therapeutics appoints dr. gopi shankar as chief development officer
Biologics expert and long-time veteran of Johnson & Johnson will be responsible for the strategic development of Larimar’s clinical and R&D programs...
February 7, 2023, 9:05 pm
Tenaya therapeutics to participate in upcoming investor conferences
SOUTH SAN FRANCISCO, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a...
February 7, 2023, 5:17 pm
Adicet bio: searching for upside in cell therapeutics
Biotechs developing CAR-T cell therapies have seen their valuations plummet in 2022 - making them an intriguing speculative buy opportunity in 2023. T...
February 7, 2023, 2:24 pm
The 7 best biotech stocks to buy for february 2023
While unpredictable compared to other sectors due to the ebb and flow of clinical trials, the best biotech ...
February 7, 2023, 1:51 pm
Indaptus therapeutics activates morristown medical center as trial site in indp-d101, its ongoing phase 1 open label clinical trial of decoy20 in patients with advanced solid tumors
NEW YORK, Feb. 07, 2023 (GLOBE NEWSWIRE) — Indaptus Therapeutics, Inc. (Nasdaq: INDP, “Indaptus” or “the Company”), a biotechnology company ...
February 7, 2023, 1:05 pm